167 related articles for article (PubMed ID: 38610011)
41. Preoperative medical therapy before surgery for uterine fibroids.
Lethaby A; Puscasiu L; Vollenhoven B
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD000547. PubMed ID: 29139105
[TBL] [Abstract][Full Text] [Related]
42. Natural history of fibroids in pregnancy: National Institute of Child Health and Human Development Fetal Growth Studies - Singletons cohort.
Mitro SD; Peddada S; Chen Z; Buck Louis GM; Gleason JL; Zhang C; Grantz KL
Fertil Steril; 2022 Oct; 118(4):656-665. PubMed ID: 35981916
[TBL] [Abstract][Full Text] [Related]
43. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.
Commandeur AE; Styer AK; Teixeira JM
Hum Reprod Update; 2015; 21(5):593-615. PubMed ID: 26141720
[TBL] [Abstract][Full Text] [Related]
44. Efficacy and safety of ultrasound-guided high intensity focused ultrasound ablation of symptomatic uterine fibroids in Black women: a preliminary study.
Zhang C; Jacobson H; Ngobese ZE; Setzen R
BJOG; 2017 Aug; 124 Suppl 3():12-17. PubMed ID: 28856855
[TBL] [Abstract][Full Text] [Related]
45. Uterine fibroids and gynecologic pain symptoms in a population-based study.
Lippman SA; Warner M; Samuels S; Olive D; Vercellini P; Eskenazi B
Fertil Steril; 2003 Dec; 80(6):1488-94. PubMed ID: 14667888
[TBL] [Abstract][Full Text] [Related]
46. "I think people should be more aware:" Uterine fibroid experiences among women living in Indiana, USA.
Dykstra C; Laily A; Marsh EE; Kasting ML; DeMaria AL
Patient Educ Couns; 2023 Feb; 107():107584. PubMed ID: 36473404
[TBL] [Abstract][Full Text] [Related]
47. Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy).
Sangkomkamhang US; Lumbiganon P; Pattanittum P
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD008994. PubMed ID: 33226133
[TBL] [Abstract][Full Text] [Related]
48. Influence of Ethnicity on Clinical Presentation and Quality of Life in Women With Uterine Fibroids: Results From a Prospective Observational Registry.
Murji A; Bedaiwy M; Singh SS; Bougie O;
J Obstet Gynaecol Can; 2020 Jun; 42(6):726-733.e1. PubMed ID: 31882290
[TBL] [Abstract][Full Text] [Related]
49. Role of ethnicity in treating uterine fibroids with ulipristal acetate.
Murji A; Crosier R; Chow T; Ye XY; Shirreff L
Fertil Steril; 2016 Oct; 106(5):1165-1169. PubMed ID: 27336213
[TBL] [Abstract][Full Text] [Related]
50. Fibroid volume, location and symptoms in women undergoing uterine artery embolization: does size or position matter?
Arleo EK; Masheb RM; Pollak J; McCarthy S; Tal MG
Int J Fertil Womens Med; 2007; 52(2-3):111-20. PubMed ID: 18320870
[TBL] [Abstract][Full Text] [Related]
51. Impact of diagnosis and treatment of uterine fibroids on quality of life and labor productivity: The Japanese online survey for uterine fibroids and quality of life (JOYFUL survey).
Koga K; Fukui M; Fujisawa M; Suzukamo Y
J Obstet Gynaecol Res; 2023 Oct; 49(10):2528-2537. PubMed ID: 37524334
[TBL] [Abstract][Full Text] [Related]
52. A randomised trial of treating fibroids with either embolisation or myomectomy to measure the effect on quality of life among women wishing to avoid hysterectomy (the FEMME study): study protocol for a randomised controlled trial.
McPherson K; Manyonda I; Lumsden MA; Belli AM; Moss J; Wu O; Middleton L; Daniels J
Trials; 2014 Nov; 15():468. PubMed ID: 25432688
[TBL] [Abstract][Full Text] [Related]
53. Management of uterine fibroids: an update of the evidence.
Viswanathan M; Hartmann K; McKoy N; Stuart G; Rankins N; Thieda P; Lux LJ; Lohr KN
Evid Rep Technol Assess (Full Rep); 2007 Jul; (154):1-122. PubMed ID: 18288885
[TBL] [Abstract][Full Text] [Related]
54. Racial/Ethnic Differences in Women's Experiences with Symptomatic Uterine Fibroids: a Qualitative Assessment.
Sengoba KS; Ghant MS; Okeigwe I; Mendoza G; Marsh EE
J Racial Ethn Health Disparities; 2017 Apr; 4(2):178-183. PubMed ID: 27068661
[TBL] [Abstract][Full Text] [Related]
55. Comparison of characteristics of fibroids in African American and white women undergoing premenopausal hysterectomy.
Moorman PG; Leppert P; Myers ER; Wang F
Fertil Steril; 2013 Mar; 99(3):768-776.e1. PubMed ID: 23199610
[TBL] [Abstract][Full Text] [Related]
56. Knowledge of uterine fibroid symptoms and presentation among African-American women: a pilot study.
Ekpo GE; Ghant MS; Woodley LM; Recht HS; McKnight T; Marsh EE
J Reprod Med; 2014; 59(9-10):448-54. PubMed ID: 25330686
[TBL] [Abstract][Full Text] [Related]
57. Growth of uterine leiomyomata among premenopausal black and white women.
Peddada SD; Laughlin SK; Miner K; Guyon JP; Haneke K; Vahdat HL; Semelka RC; Kowalik A; Armao D; Davis B; Baird DD
Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19887-92. PubMed ID: 19047643
[TBL] [Abstract][Full Text] [Related]
58. Early-life exposures and early-onset uterine leiomyomata in black women in the Sister Study.
D'Aloisio AA; Baird DD; DeRoo LA; Sandler DP
Environ Health Perspect; 2012 Mar; 120(3):406-12. PubMed ID: 22049383
[TBL] [Abstract][Full Text] [Related]
59. Self-Reported Reproductive Tract Infections and Ultrasound Diagnosed Uterine Fibroids in African-American Women.
Moore KR; Cole SR; Dittmer DP; Schoenbach VJ; Smith JS; Baird DD
J Womens Health (Larchmt); 2015 Jun; 24(6):489-95. PubMed ID: 25901468
[TBL] [Abstract][Full Text] [Related]
60. Measurement of changes in uterine and fibroid volume during treatment of heavy menstrual bleeding (HMB).
Yin K; Whitaker L; Hojo E; McLenachan S; Walker J; McKillop G; Stubbs C; Priest L; Cruz M; Roberts N; Critchley H
Hum Reprod Open; 2023; 2023(3):hoad021. PubMed ID: 37304815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
